UNLABELLED: To determine the clinical manifestations and interfamilial variability of patients diagnosed with a mitochondrial cardiomyopathy, we reviewed the charts of 14 patients with cardiomyopathy out of 59 patients with mitochondrial disorders who attended the mitochondrial disease clinic at Wolfson Medical Center from 1996 to 2001. All patients underwent a metabolic evaluation including blood lactate, pyruvate, carnitine, and amino acids and urine organic acids. Respiratory chain enzymes were assessed in 10 patients. The mitochondrial DNA (mtDNA) was assessed for mutations. The age at presentation ranged between 6 months and 24 years. Six of the patients died, 5 from heart failure. The cardiomyopathy was hypertrophic in 10 and dilated in 4. Conduction and rhythm abnormalities were present in 6. Eleven patients had family members with mitochondrial disorders. All the patients had additional involvement of one or more systems. Seven patients exhibited a deficiency of a respiratory chain enzyme in the muscle. The MELAS mtDNA point mutation (3243) was found in one patient. Blood lactic acid levels were increased in 5. Brain MRI abnormalities were observed in 4. CONCLUSIONS: Mitochondrial dysfunction frequently affects the heart and may cause both hypertrophic and dilated cardiomyopathy. The cardiomyopathy is usually a part of a multisystem involvement and may rarely be isolated. The course may be stable for many years, but rapid deterioration may occur. Understanding the biochemical and genetic features of these diseases will enable us to comprehend the clinical heterogeneity of these disorders.
UNLABELLED: To determine the clinical manifestations and interfamilial variability of patients diagnosed with a mitochondrial cardiomyopathy, we reviewed the charts of 14 patients with cardiomyopathy out of 59 patients with mitochondrial disorders who attended the mitochondrial disease clinic at Wolfson Medical Center from 1996 to 2001. All patients underwent a metabolic evaluation including blood lactate, pyruvate, carnitine, and amino acids and urine organic acids. Respiratory chain enzymes were assessed in 10 patients. The mitochondrial DNA (mtDNA) was assessed for mutations. The age at presentation ranged between 6 months and 24 years. Six of the patients died, 5 from heart failure. The cardiomyopathy was hypertrophic in 10 and dilated in 4. Conduction and rhythm abnormalities were present in 6. Eleven patients had family members with mitochondrial disorders. All the patients had additional involvement of one or more systems. Seven patients exhibited a deficiency of a respiratory chain enzyme in the muscle. The MELAS mtDNA point mutation (3243) was found in one patient. Blood lactic acid levels were increased in 5. Brain MRI abnormalities were observed in 4. CONCLUSIONS:Mitochondrial dysfunction frequently affects the heart and may cause both hypertrophic and dilated cardiomyopathy. The cardiomyopathy is usually a part of a multisystem involvement and may rarely be isolated. The course may be stable for many years, but rapid deterioration may occur. Understanding the biochemical and genetic features of these diseases will enable us to comprehend the clinical heterogeneity of these disorders.
Authors: A Nissenkorn; A Zeharia; D Lev; A Fatal-Valevski; V Barash; A Gutman; S Harel; T Lerman-Sagie Journal: Arch Dis Child Date: 1999-09 Impact factor: 3.791
Authors: U Caruso; A Adami; E Bertini; A B Burlina; F Carnevale; R Cerone; C Dionisi-Vici; G Giordano; E Leuzzi; G Parenti; S Savasta; G Uziel; M Zeviani Journal: J Inherit Metab Dis Date: 1996 Impact factor: 4.982
Authors: M Zeviani; C Gellera; C Antozzi; M Rimoldi; L Morandi; F Villani; V Tiranti; S DiDonato Journal: Lancet Date: 1991-07-20 Impact factor: 79.321
Authors: I Valnot; J C von Kleist-Retzow; A Barrientos; M Gorbatyuk; J W Taanman; B Mehaye; P Rustin; A Tzagoloff; A Munnich; A Rötig Journal: Hum Mol Genet Date: 2000-05-01 Impact factor: 6.150
Authors: D Bonnet; P de Lonlay; I Gautier; P Rustin; A Rötig; J Kachaner; P Acar; J LeBidois; A Munnich; D Sidi Journal: Eur Heart J Date: 1998-05 Impact factor: 29.983
Authors: V Tiranti; K Hoertnagel; R Carrozzo; C Galimberti; M Munaro; M Granatiero; L Zelante; P Gasparini; R Marzella; M Rocchi; M P Bayona-Bafaluy; J A Enriquez; G Uziel; E Bertini; C Dionisi-Vici; B Franco; T Meitinger; M Zeviani Journal: Am J Hum Genet Date: 1998-12 Impact factor: 11.025
Authors: Ali Yilmaz; Hans-Jürgen Gdynia; Matthias Ponfick; Sabine Rösch; Alfred Lindner; Albert C Ludolph; Udo Sechtem Journal: Clin Res Cardiol Date: 2011-12-06 Impact factor: 5.460
Authors: Paul de Laat; Saskia Koene; Lambert P W J Vd Heuvel; Richard J T Rodenburg; Mirian C H Janssen; Jan A M Smeitink Journal: JIMD Rep Date: 2012-07-06
Authors: Ayman W El-Hattab; Lisa T Emrick; Jean W Hsu; Sirisak Chanprasert; Farook Jahoor; Fernando Scaglia; William J Craigen Journal: Mitochondrion Date: 2014-07-30 Impact factor: 4.160
Authors: Richard H Haas; Sumit Parikh; Marni J Falk; Russell P Saneto; Nicole I Wolf; Niklas Darin; Lee-Jun Wong; Bruce H Cohen; Robert K Naviaux Journal: Mol Genet Metab Date: 2008-02-01 Impact factor: 4.797
Authors: Cristina Mazzaccara; Bruno Mirra; Ferdinando Barretta; Martina Caiazza; Barbara Lombardo; Olga Scudiero; Nadia Tinto; Giuseppe Limongelli; Giulia Frisso Journal: Int J Mol Sci Date: 2021-05-27 Impact factor: 6.208